Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an announcement.
Wai Chun Bio-Technology Ltd. has announced a further postponement of its Extraordinary General Meeting (EGM) to June 30, 2025, due to venue repairs. This delay affects the timetable for the proposed capital reorganization and the alteration of terms for existing convertible bonds, impacting shareholders’ ability to attend and vote. The change in schedule also modifies the book closure period for determining shareholder eligibility, with the register of members now closed from June 25 to June 30, 2025.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. operates in the biotechnology industry, focusing on the development and commercialization of bio-technology products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 155,016
Technical Sentiment Signal: Hold
Current Market Cap: HK$22.67M
Learn more about 0660 stock on TipRanks’ Stock Analysis page.

